2024    2023    2022    2021    2020    2019    2018    2017    2016   

2017

Articles

131 - 

Evaluation of adherence to French clinical practice guidelines in the management of pregnancy loss issued by the French College of Obstetricians and Gynecologists, one year after publication: A vignette-based study

S. Le Gouic, V. Lavoue, M. Mimouni, Jérémy Lévêque, C. Huchon et al.

Journal of Gynecology Obstetrics and Human Reproduction, 2017, 46 (5), pp.393-398.

DOI : https://doi.org/10.1016/j.jogoh.2017.03.005

Pubmed : 28934082

 

132 - 

Emerging Estrogenic Pollutants in the Aquatic Environment and Breast Cancer

Sylvain Lecomte, Denis Habauzit, Thierry D. Charlier, Farzad Pakdel

Genes, 2017, 8 (9), pp.229.

DOI : https://doi.org/10.3390/genes8090229

Pubmed : 28914763

 

133 - 

Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?

Sylvain Lecomte, Florence Demay, François Ferrière, Farzad Pakdel

International Journal of Molecular Sciences, 2017, 18 (7), pp.1381.

DOI : https://doi.org/10.3390/ijms18071381

Pubmed : 28657580

 

134 - 

Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cells

Sylvain Lecomte, Frédéric Chalmel, François Ferrière, F. Percevault, Nicolas Plu et al.

Cell Communication and Signaling, 2017, 15 (7), pp.26.

DOI : https://doi.org/10.1186/s12964-017-0182-1

Pubmed : 28666461

 

135 - 

Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation

Sylvain Lecomte, Marie Lelong, Gaëlle Bourgine, Théo Efstathiou, Christian Saligaut et al.

Toxicology and Applied Pharmacology, 2017, 325, pp.61-70.

DOI : https://doi.org/10.1016/j.taap.2017.04.005

Pubmed : 28396216

 

136 - 

Synthesis and biological properties of galactofuranosyl-containing fluorescent dyes

Laurent Legentil, Sorya Belaz, Jean-Pierre Gangneux, Florence Robert-Gangneux, Vincent Ferrières et al.

Bioorganic and Medicinal Chemistry Letters, 2017, 27 (2), pp.152-155.

DOI : https://doi.org/10.1016/j.bmcl.2016.11.090

Pubmed : 27956346

 

137 - 

Fluctuation Does Not Mean Variability: A Pharmacokinetic Point of View

F. Lemaître, C. Tron, M. Rayar

American Journal of Transplantation, 2017, 17 (6), pp.1691-1692.

DOI : https://doi.org/10.1111/ajt.14237

Pubmed : 28226402

 

138 - 

Practices of infectious control management during neutropenia: A survey from 149 French hospitals

N Lequilliec, R Raymond, D Vanjak, N Baghdadi, H Boulestreau et al.

Journal of Medical Mycology = Journal de Mycologie Médicale, 2017, 27 (2), pp.227-231.

DOI : https://doi.org/10.1016/j.mycmed.2017.02.006

Pubmed : 28314678

 

139 - 

Silica-associated systemic sclerosis in 2017: 60 years after Erasmus, where do we stand?

Alain Lescoat, Catherine Cavalin, Odile Macchi, Patrick Jego, Paul-Andre Rosental et al.

Clinical Rheumatology, 2017, 36 (5), pp.1209-1210.

DOI : https://doi.org/10.1007/s10067-017-3576-y

Pubmed : 28213786

 

140 - 

CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis

Alain Lescoat, Valérie Lecureur, Mikael Roussel, Beatrice Ly Sunnaram, Alice Ballerie et al.

Clinical Rheumatology, 2017, 36 (7), pp.1649--1654.

DOI : https://doi.org/10.1007/s10067-017-3597-6

Pubmed : 28293753